BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 18193817)

  • 1. [Adverse effects and toxicity of beta blockers].
    Bosković B; Dobrić S; Stojiljković MP
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():74-80. PubMed ID: 18193817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse CNS-effects of beta-adrenoceptor blockers.
    Gleiter CH; Deckert J
    Pharmacopsychiatry; 1996 Nov; 29(6):201-11. PubMed ID: 8956349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poisoning with anti-hypertensive drugs: beta-adrenoceptor blocker drugs.
    Lip GY; Ferner RE
    J Hum Hypertens; 1995 Apr; 9(4):213-21. PubMed ID: 7595901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-blocker and calcium channel blocker toxicity.
    Kerns W; Kline J; Ford MD
    Emerg Med Clin North Am; 1994 May; 12(2):365-90. PubMed ID: 7910555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug eruptions caused by beta-blockers].
    Bonnetblanc JM
    Ann Med Interne (Paris); 1984; 135(8):639-41. PubMed ID: 6152136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
    Califf RM; Lokhnygina Y; Velazquez EJ; McMurray JJ; Leimberger JD; Lewis EF; Diaz R; Murin J; Pfeffer MA
    Am J Cardiol; 2009 Jul; 104(2):151-7. PubMed ID: 19576338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of beta-adrenergic blocker and calcium channel antagonist toxicity.
    Kerns W
    Emerg Med Clin North Am; 2007 May; 25(2):309-31; abstract viii. PubMed ID: 17482022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW
    Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse reactions to beta-blocking drugs: a review.
    Petrie JC; Galloway DB; Jeffers TA; Webster J
    Postgrad Med J; 1976; 52 Suppl 4():63-9. PubMed ID: 9632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-blocker therapy and the risk of anaphylaxis.
    Toogood JH
    CMAJ; 1987 May; 136(9):929-33. PubMed ID: 2882832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-myocardial infarction beta-blocker therapy: the bradycardia conundrum. Rationale and design for the Pacemaker & beta-blocker therapy post-MI (PACE-MI) trial.
    Goldberger JJ; Bonow RO; Cuffe M; Dyer A; Greenland P; Rosenberg Y; O'Rourke R; Shah PK; Smith S
    Am Heart J; 2008 Mar; 155(3):455-64. PubMed ID: 18294477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High efficacy of beta-blockers in long-QT syndrome type 1: contribution of noncompliance and QT-prolonging drugs to the occurrence of beta-blocker treatment "failures".
    Vincent GM; Schwartz PJ; Denjoy I; Swan H; Bithell C; Spazzolini C; Crotti L; Piippo K; Lupoglazoff JM; Villain E; Priori SG; Napolitano C; Zhang L
    Circulation; 2009 Jan; 119(2):215-21. PubMed ID: 19118258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on beta blockers.
    Williams JR
    AANA J; 1989 Feb; 57(1):29-36. PubMed ID: 2564714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Other important applications for beta-blockers in high-risk patients.
    Egan BM; Chilton RJ
    Postgrad Med; 2003 Dec; 114(6 Suppl Role):35-48. PubMed ID: 19667668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium and beta receptor antagonist overdose: a review and update of pharmacological principles and management.
    Newton CR; Delgado JH; Gomez HF
    Semin Respir Crit Care Med; 2002 Feb; 23(1):19-25. PubMed ID: 16088594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Principal pharmacological properties of different beta-blockers, possibilities and new perspectives of their uses].
    Antelava N; Antelava A; Pachkoria K; Pirtskhalaishvili N
    Georgian Med News; 2006 Dec; (141):38-46. PubMed ID: 17261885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-adrenoceptor blocking drugs: adverse reactions and drug interactions.
    Kendall MJ; Beeley L
    Pharmacol Ther; 1983; 21(3):351-69. PubMed ID: 6138787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Side-effects and interactions of beta-adrenergic blockers].
    Vrhovac B
    Lijec Vjesn; 1984; 106(11-12):498-500. PubMed ID: 6151618
    [No Abstract]   [Full Text] [Related]  

  • 20. Adverse sequelae with combined use of beta-blockers and epinephrine.
    Kevorkian G
    Gen Dent; 1987; 35(4):298-300. PubMed ID: 2895036
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.